The cervical cancer nine-valent vaccine costs about $1,300 per dose, and a total of three doses are required, and the vaccination is completed within one year. The cervical cancer 9-valent vaccine can clinically prevent more than 92% of cervical and vaginal cancers as well as vulvar and anal cancers, so it is recommended that the vaccination be given if available. However, it is important to avoid menstruation during the vaccination period, and the cervical cancer vaccine should not be given during breastfeeding or pregnancy. For married women or women with a history of sexual intercourse, cervical cancer screening must be done before cervical cancer vaccination, mainly to find out whether there are lesions on the cervical epithelium or whether there is high-risk HPV infection, and then based on the results, it can be decided whether cervical cancer vaccination can be given.